Harald Wajant
Molecular Biology · 2001–2003
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 26 citations into it; #5,878 of 17,773 by trust here, #10,047 by citations
- Cancer Research — 20 citations into it; #1,231 of 1,780 by trust here, #1,066 by citations
- Immunology — 18 citations into it; #639 of 2,160 by trust here, #1,262 by citations
Whom Harald Wajant trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Harald Wajant overall
- Susan A. Elmore
- M. Soengas
- P. Storz
- P. Paoli
- E. Giannoni
- M. Taddei
- L. Galluzzi
- Robert F. Schwabe
- Roman Fischer
- J. Mcafoose
Papers from Harald Wajant's perspective
Ordered by how strongly the researchers Harald Wajant trusts endorse each paper. Same corpus, a different order for every researcher.
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death (Science)
- Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. (Cell)
- Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. (Science)
- Structural and biochemical basis of apoptotic activation by Smac/DIABLO (Nature)
- Signal transduction by tumor necrosis factor and its relatives. (Trends in Cell Biology)
- ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis (EMBO Reports)
- Four deaths and a funeral: from caspases to alternative mechanisms (Nature reviews. Molecular cell biology)
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule (Nature Immunology)
- Mammalian MAP kinase signalling cascades (Nature)
- The expanding role of mitochondria in apoptosis. (Genes & Development)
Their papers
- The Fas Signaling Pathway: More Than a Paradigm (2002) — 1,008 citations
- NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling (2001) — 677 citations
- Tumor necrosis factor signaling (2003) — 2,531 citations